UCHealth Poudre Valley Hospital

Fort Collins, Colorado 80528

3 studies enrolling now · 10 studies all time

What they study most

Advanced Solid Tumor, Breast Cancer, COVID-19, Colorectal Cancer, Covid19, Fallopian Tube Cancer, Head and Neck Squamous Cell Carcinoma, Metastatic Pancreas Adenocarcinoma, Multiple Myeloma, Non-small Cell Lung Cancer, Ovarian Carcinoma, PDAC

Studies at this site

• MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) — Recruiting now
• Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) — Recruiting now
• A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments — Recruiting now
• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C) — Running, not enrolling
• A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer. — Running, not enrolling
• A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors — Stopped early
• Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol — Status unconfirmed
• An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients — Completed
• Convalescent Plasma for the Treatment of Patients With COVID-19 — NO_LONGER_AVAILABLE